Karyopharm Therapeutics Inc. · 1 week ago
Summer Intern – Clinical Development
Karyopharm Therapeutics Inc. is dedicated to pioneering novel cancer therapies in a supportive and flexible environment. They are seeking a Summer Intern for their Clinical Development team to gain real-world experience in drug development and contribute to publishing results from clinical trials.
Health CareMedicalPharmaceutical
Responsibilities
Assist in the preparation, review, and submission of manuscripts to medical journals, conferences, and other forums
Review the medical portions of regulatory documents to ensure accurate description of the efficacy and safety of regimens in clinical trials
Conduct research on the treatment landscape of the cancer of interest
Participate in cross-functional meetings and collaborate with departments such as Clinical Operations, Clinical Development, Quality, Pharmaceutical Sciences, etc
Qualification
Required
Currently pursuing a college degree with intention to go on to medical school or are actively in medical training
Strong analytical skills and attention to detail
Excellent written and verbal communication skills
Ability to work independently and collaboratively in a fast-paced environment
Proficiency in Microsoft Office Suite (Word, Excel, PowerPoint) as well as reference software, such as Endnote or Zotero
A working knowledge of physiology, statistics, and molecular biology
Ability to work independently and collaboratively in a fast-paced environment
You feel a strong connection with our ICARE values (Innovation, Courage, Alignment & Accountability, Resilience, and Energy)
You demonstrate enthusiasm for learning and a commitment to career development
Must be able to complete the Karyopharm Internship Program 27 May – 08 Aug 2025
Currently enrolled high school or college (bachelor's program) student
Student must be returning to school in the Fall Term
Must have a minimum GPA of 3.0
Must be highly organized and have the ability to work independently and collaboratively as a team
Clear, concise verbal & written communication
Company
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Funding
Current Stage
Public CompanyTotal Funding
$607.2MKey Investors
Avidity PartnersForesite CapitalDelphi Ventures
2025-10-08Post Ipo Equity· $33M
2025-10-08Post Ipo Debt· $27.5M
2022-12-05Post Ipo Equity· $165M
Leadership Team
Recent News
2025-11-08
Company data provided by crunchbase